Abstract--The gene expression data generated by the Microarray technology for thousands of genes simultaneously provide huge amounts of biomedical data in forms of gene expression profiles. This generated gene data include complex variations of expression levels of thousands of gene in the classes of samples. The gene level variations allow for classifying and clustering the samples based on only a small subset of genes. In this work, we want to identify the most significant genes that demonstrate the highest capabilities of discrimination between the classes of samples. We present a new gene selection technique for extracting the most significant genes from the huge gene/feature space in a given gene expression dataset. Our method is based on computing the discriminating capability of each gene, and classifying the data according to only those most significant genes that have highest discriminating capabilities. We also adapted from text categorization and information retrieval five feature selection techniques into the gene selection task to compare with our method. We evaluated the method using four well-known gene expression datasets. The experimental results showed that our method produces impressive and competitive results in terms of classification performance with few selected genes compared with the existing techniques.
I. INTRODUCTION
The DNA Microarray technology was first introduced in 1995 for measuring the expression levels of thousands of genes simultaneously [1, 2, 7] . These genes are amplified by Polymerase Chain Reaction (PCR) technique. A robot spots the PCR resulted genes onto an ordinary glass microscope slide. The next process denatures and links the spotted DNA to the glass slide [7] . Each microscope slide contains a gridlike pattern like an array with thousands of spots of amplified copies of each gene. Immobilized DNA on the microarray will be hybridized with a probe, which is a known labeled DNA sequence. In order to make the probe, mRNA is isolated from control or diseased samples, and converted into cDNA. The nucleotides 1 used to produce cDNA include a green dye (Cy3) or a red dye (Cy5) [5, 7] . Since each microarray contains thousands of DNA spots, the output numeric data is too much to be processed manually. So, there is a great demand for efficient methods for analysis and manipulation of gene expression data. These data include H. Al-Mubaid and N. Ghaffari are with the Computer Science department, University of Houston-Clear Lake, Houston, TX 77058 USA (e-mail: hisham@uhcl.edu, tel: +1 (282) complex variations among expression levels of each gene in the normal vs disease tissue samples, which allows for classifying and clustering the samples into normal vs disease based on only a small subset of the genes. The goal of this work is to extract those genes that demonstrate high discriminating capabilities between the classes of samples. We propose a new method for gene classification and extraction using various feature selection techniques. Our method is based on computing thresholds and discriminating capabilities of each gene and classifying the data according to only those genes that have highest capabilities to discriminate between the two classes (viz. normal, disease) of samples. The method extracts very small subsets of useful salient genes that can improve the classification accuracy of tissue samples. We applied the method on four well-known gene expression datasets. We also applied five other feature selection techniques from the text classification literature to compare with our method. The method produces encouraging and competitive results in terms of classification performance compared with recent similar techniques. A number of methods have been proposed and applied into gene expression profiles in the last few decades. Paul and Iba [1] modified the Probabilistic Model Building Genetic Algorithm (PMBGA) into a Random PMBGA (RPMBGA) for gene selection. They tried to reduce the size of gene subsets while keeping accuracy of classification in the high level. For the same task, Liu et al. [2] used the neural network for gene expression profiles. They used 100 iterations of resampled data as an input to their architecture, which consists of three neural network feature selection methods. They used Kent Ridge datasets [11] and found 100% accuracy for ALLAML and Lung Cancer data, and 97.06% for the prostate cancer dataset [2] .
II. THE PROPOSED METHODS
DNA Microarray technology produces 2D representation of gene expression levels containing 2 or more classes of (tissue) samples. The variation in the expression levels of each gene between class-1 vs. class-2 determines how much that gene is related to one of the two classes. The gene that demonstrates high differences in its expression levels between class-1 and class-2 is a good "significant" gene that is typically highly related with the disease of class-2 samples (assuming normal vs disease tissue samples). Our method for gene selection is adapted from the feature selection techniques in the text categorization (TC) and information retrieval (IR) literatures [12, 13] . These feature selection techniques, like Mutual Information and Chi-square, are based on selecting the salient features from a huge feature space based on the feature values in the underlying classes. Our method is based on computing a discriminating value V for each gene in the dataset. A gene with the highest V value is the one that have the highest differences in its expression levels between the two classes of samples. Then we sort the genes based on their computed V values, select the top n genes, and delete the remaining (unselected) genes for the data. Before we delve into the details we explain how we compute the thresholds which are needed for our feature selection techniques.
A. Selecting Thresholds
We want to find such a threshold t that separates the gene expression levels in class-1 for its levels in class-2 with the least noise. For example, if the expression levels of gene g in class-1 are all positive and in class-2 are all negative, then in this case a threshold value of zero (t=0) is the best value that gives the least noise (zero noise). For that, we examine, for each gene, all the values from the minimum gene expression value in all samples to the maximum one and select the value that gives lowest noise as a threshold.
B. Computing V Values
Suppose we are given a gene expression matrix with two classes of samples: classe-1 and class-2. Assume further that we have a threshold value t. ] is a good indicator of how much a gene differentiates between the two classes. Thus, we compute for each gene a V score using our method as follows:
This method (Eq.1) selects the genes that demonstrate the highest separation in their expression values from class-1 to class-2. Then, to evaluate our method and compare it with the similar feature selection techniques, we borrowed and adapted from the IR and TC research four other feature selection techniques: Mutual Information (MI), Chi-square (X 2 ), GSS-Coefficient, and Odd Ratio (OR) [12, 13] and are defined as follows:
where N is the total number of samples in both classes. We further adapted from MI (Eq.2) a new feature selection technique by giving more weight to the a value of each gene and to the difference (a -b). So we multiplied MI by a and also by (a -b), and the resulting formula are shown in Eq.6:
C. Learning and classification
We evaluate the selected gene subset using machine learning with a two-class classification based on only the n selected genes. We use support vector machines (SVM) [9, 10] for learning and classification. Numerous theoretical justifications exist in the literature to support SVM [10] . We take two classes at a time and apply SVM to train on them and produce a classifier (model). The classifier will then be used in the classification phase to classify the testing samples. We use the SVM-light implementation with the default parameters (svmlight.joachims.org).
III. EXPERIMENTS AND RESULTS

A. Datasets
We used four microarray datasets to evaluate our method: ALL-AML Leukemia [4] , Lung cancer [3] , Prostate cancer [2] , and the Diffuse Large B-cell Lymphoma (DLBCL) [5] . Table 1 contains the details of these datasets. These datasets (downloaded from [11] ) are used commonly for sample classification and gene clustering research.
B. Results and Discussion
We ran our method to select subsets of most significant genes for a number of subset sizes. Subsets with size of 1, 2,… ,10, 50 and 100 genes were selected. We evaluated our method (Eq.1) using the four datasets described in Table 1. Table 2 summarizes the results; each dataset was tested with subsets of 1, 2,…,10 selected genes. Tables 3, 4 , 5, 6. From these experimental results we can see that our method is superior in selecting the most significant genes. The classification performance with only ten genes or less showed that our technique can produce accuracy on average 94.00% to 99.71% (Table 2) , whereas the other four methods are lagging behind, from which, X 2 comes next with average accuracy of one to ten genes on the four datasets ranges from 93.00% to 97.06%. Moreover, we examined our second technique (MI-2) that we adapted from MI on the same setting, and the results are in Table 7 . These results, in Table 7 , can be easily compared with the MI results in Table 3 to realize that our technique (MI-2) outperforms MI significantly. For example, on the Lung Cancer dataset, our method gave average accuracy of 98.93% (Table 7) while MI produced for the same dataset 67.32% (Table 3) . Furthermore, if we compare the performance of our MI-2 technique to X 2 , GSS, and OR (Tables 4, 5, 6) we again notice that it is competitive and effective in selecting the significant genes. In another set of experiments, we used 50 and 100 genes selected by our method and by the other methods, and the results are in Table 8 . Again, our method outperforms the other techniques on three out of the four datasets (Table 8 ). We also notice that the GSS-Coefficient technique works very well in the case of 50 and 100 genes. Finally, Table 9 summarizes, for each dataset, the average accuracy of one to ten genes selected using our method and the other four feature selection techniques. As we can see in Table 9 that our method on average (of 1 to 10 genes) produced the best accuracy results on three datasets AML-ALL, Prostate cancer, and DLBCL. And in the fourth dataset (Lung cancer) our method produced the second best accuracy (98.53%) and very close to the best accuracy of 98.93% produced by the GSS method. 
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IV. CONCLUSION
This paper explores feature selection techniques within the context of gene expression data for sample classification. We presented two new gene selection techniques and compared them with several features selection techniques adapted from the information retrieval literature. The methods extract small gene subsets that allow for sample classification with high accuracy. Since the gene expression profiles are usually produced from disease and normal tissue samples, the extracted genes are considered as related with that underlying disease. Furthermore, identifying a small group of genes that can classify the gene expression data with very high accuracy leads to the discovery that these selected genes are associated with that disease studied in the gene expression dataset. In the experimental results, the proposed techniques demonstrated superior or very competitive performance in terms of accuracy of sample classification. In the future work, we plan to investigate how we can support our findings by exploiting the huge amounts of biomedical literature (e.g. Medline) using text-mining techniques. 
